Answers are grounded in this paper and cite their sources.
A stroke is a neurological disease that causes damage to the brain due to an obstruction of blood supply. Stroke prevalence has shown a drastic increase as the world's population ages. The effects of a stroke can lead to long-lasting brain damage, long-term disability, or death. Current treatment options are limited, and their efficacy is dependent on the element of time. However, stem cell therapy may provide an alternative means of treatment for stroke patients. The ability of mesenchymal stem cells to self-renew and differentiate into multiple different cell types, including neurons and glial cells, shows promise for stroke treatment. Therapeutically, MSCs are capable of diminishing inflammation through immunomodulation, promoting therapeutic effects through the release of trophic factors, inducing angiogenesis, increasing the proliferation of neuroblasts, and promoting the replacement of damaged cells. Preclinically and clinically, MSC therapy appears to be safe; however, treatment efficacy has yet to be established.
No takes yet. Share an insight, caveat, or question.
Stock et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: